wellrank.ai

Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

ClaudequalifiedCollected Jun 12, 2026, 10:29 UTC

Verbatim response from Claude

This is a fast-moving regulatory area, so I want to be straightforward with you:

What Happened

The FDA declared the semaglutide shortage over in early 2025, which restricted most compounding pharmacies from making compounded semaglutide (Ozempic/Wegovy). Tirzepatide (Mounjaro/Zepbound) followed similarly.

Services Still Navigating This Space

Hims & Hers - Fought back legally and continued offering compounded semaglutide for a period, though their status has shifted with ongoing legal battles.

Nuvation/Mochi Health - Has worked with compounding partners and personalized dosing formulations.

Ivy RX - Focused on compounded options with add-ins (like B12) that may fall under different rules.

Important Caveats

  • Status changes frequently - what's available this week may not be next week
  • Some services use 503A vs 503B pharmacies, which have different rules
  • "Personalized" compounds with additives occupy a legal gray area
  • Prices and availability vary significantly by state

My Honest Recommendation

Check directly with the service today and ask specifically about their current legal status and pharmacy sourcing. Also consider whether brand-name options with manufacturer coupons (Lilly's savings program, etc.) might be comparable in cost.

Would you like help comparing brand-name access options instead?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.

Which telehealth services still offer compounded GLP-1s after the FDA crackdown? | Claude answer | WellRank